I am 42, female with UC and anemia. How to manage them?

Question

Hello doctor,

I am a 42-year-old female diagnosed with ulcerative colitis (UC) three years ago. My most recent colonoscopy, performed last month, showed continuous inflammation from the rectum to the sigmoid colon. My fecal calprotectin level was 420 µg/g, and C-reactive protein was 18 mg/L. I also have iron-deficiency anemia, with my latest hemoglobin at 9.6 g/dL and ferritin at 8 ng/mL.

I experience frequent diarrhea, about 6 to 7 loose stools per day, with occasional blood and mucus, along with abdominal cramps and fatigue. I am currently taking Mesalamine 2.4 g daily and oral iron supplements. My BMI is 20.5 kg/m², and I have unintentionally lost 8.82 pounds in the past three months. My vitamin B12 level is borderline at 220 pg/mL. I avoid dairy and spicy foods as they worsen my symptoms. I do not smoke or consume alcohol.

I am concerned about persistent flares, worsening anemia, and potential long-term complications. I would like to know whether any advanced therapies or biologics could help achieve better disease control while also addressing my anemia.

Please help.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

Your history of ulcerative colitis with persistent inflammation from the rectum to the sigmoid colon, elevated fecal calprotectin and CRP (C-reactive protein), and ongoing symptoms despite Mesalamine suggest that your disease is in a moderate to severe active phase.

Given the frequency of diarrhea, presence of blood and mucus, abdominal cramps, weight loss, and anemia, it appears that your current therapy is not adequately controlling inflammation. In such cases, escalation to advanced therapy is warranted.

Options include immunomodulators such as Azathioprine or 6-Mercaptopurine, and biologics such as anti-TNF (tumor necrosis factor) agents such as Infliximab, Adalimumab, and Golimumab, anti-integrin therapy such as Vedolizumab, or anti-IL-12/23 (interleukin) therapy (Ustekinumab). These medications aim to achieve mucosal healing, reduce flare frequency, and minimize long-term complications such as colorectal cancer.

Given your anemia and low ferritin, intravenous iron is preferred over oral supplementation in active disease, as it bypasses gut inflammation and restores iron stores more effectively. Borderline vitamin B12 should also be monitored and supplemented if it declines further, especially since malabsorption and dietary restriction can worsen deficiency.

Close follow-up is important to tailor treatment, monitor for medication side effects, and adjust therapy based on clinical response and objective markers of inflammation. Achieving deep remission will help improve your anemia, quality of life, and long-term prognosis.

I hope this has helped you.

Please feel free to reach out to me again if you have further queries.

Thank you.